The mutagenic potential of 1 , 3 -bis[3-(l -octoxymethyI )imidazoliumJpropane dichloride dihydrate was assessed by using the Ames Salmonella/Mammialian Microsome Mutagenicity Test. Tester strains TA97, TA98, TAlOO, TAlO2, aA574nd TA1538 were exposed to doses ranging from 0.4 mg/plate to 0.0000128 mg/plate. The test compound was not mutagenic under conditions of this test.
A copy of the final report, study protocol, retired SOP's, stability and purity data on the test compound, and an aliquot of the test compound will be retained in the LAIR Archives. 
1,3-BIS[3-(I-OCTOXYMETHYL) IMIDAZOLIUM]PROPANE DICHLORIDE DIHYDRATE was synthesized for a United States Army Medical
Research and Development Command program charged with developing more effective oximes for treatment of nerve agent poisoning. The Ames Test is one of a series of tests in which these compounds will be evaluated to determine their relative potential for further development.
The Ames Salmonella/Mammalian Microsome Mutagenicity
Test is a short-term screening test that utilizes histidine auxotrophic mutant strains of Salmonella typhimurium to detect compounds that are potentially mutagenic in mammals. A mammalian microsomal enzyme system is incorporated in the test to increase sensitivity by simulating in vivo metabolic activation of the test compound. The Ames Test is an inexpensive yet highly predictive and reliable test for detecting mutagenic activity and thus carcinogenic potential (1).
This evaluation of 1,3-BIS[3-(l-OCTOXYMETHYL) IMIDAZOLIUM]PROPANE DICHLORIDE DIHYDRATE utilizes a revision of the Ames Salmonella/Mammalian Microsome Mutagenicity Test (2).
Two new tester strains, a frame-shift strain (TA97) and a strain carrying an ochre mutation on a multicopy plasmid (TAl02), are added to the standard tester set.
Objective of the Study
The objective of this study was to determine the mutagenic potential of 1,3-BIS(3-(I-OCTOXYMETHYL) IMIDAZOLIUM) PROPANE DICHLORIDE DIHYDRATE (LAIR Code TP67) by using the revised Ames Salmonella/Mammalian Microsome Mutagenicity Test. 
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MATERIALS AND METHODS
Chemical Preparation
On the day of dosing, 100 mg of the test compound was measured into a sterile vial and dissolved in glass distilled water to achieve a 5% (w/v) solution. Aliquots of this solution were used to dose the test plates.
rest Strains
Salmonella strains TA97, TA98, TAl00, TA102, TA1537, and TA1538 obtained directly from Dr. Bruce Ames, University of California, Berkeley, were used. These strains were maintained in our laboratory in liquid nitrogen. Quality control tests were run concurrently with the test substance to establish the validity of their special features and to determine the spontaneous reversion rate. Descriptions of the strains, their genetic markers, and the methods for strain validation are given in the LAIR SOP, OP-STX-l (4). A detailed. description of the methodology is given in LAIR SOP, OP-STX-l (4).
Toxicity Tests:
Toxicity tests were conducted to determine a sublethal concentration of the test substance. This toxicity level was found by using minimal glucose agar (MGA) plates, concentrations of 1,3-BIS[3-(l-OCTOXYMETHYL) IMIDAZOLIUM] PROPANE DICHLORIDE DIHYDRATE ranging from 1.6 x 10-3 mg/plate to 5 mg/plate, and approximately 108 cells of TA100 per plate. Top agar containing trace amounts of histidine and biotin was placed on the plates. Strain verification was confirmed on the bacteria, along with a determination of the spontaneous reversion rate. After incubation, the growth on the plates was observed. Since the three highest doses showed a decreased number of macrocolonies (below the spontaneous rate) and an observable reduction in the density of the background lawn, the highest dose selected for the mutagenicity test was 0.04 mg/plate.
Mutagenicity Test:
The test substance was evaluated over a 1000-fold range of concentrations, decreasing from the minimum toxic level (the maximum or limit dose) by a dilution factor of 5, both with and without 0.5 ml of the S-9 microsome fraction. The S-9 (batch R-315) was purchased from Microbiological Associates Inc. (Bethesda, MD) .
The optimal titer of this S-9, as determined by Microbiological Associates Inc., was 0.75 mg protein/plate. After all the ingredients were added, the top agar was mixed, then overlaid on MGA plates. These plates contained 2% glucose and Vogel Bonner "E" concentrate (5).
Plates were incubated upside down in the dark at 37cC for 48 hours. Plates were prepared in triplicate, and the average revertant counts were recorded. The average number of revertants at each dose level was compared to the average number of spontaneous revertants (negative control).
The spontaneous reversion rate (with and without S-9) was monitored by averaging the counts from two determinations run simultaneously with the test compound. The spontaneous reversion rate was determined by inoculating one set of plates before and one set after the test compound plates so that any change in spontaneous reversion rate during the dosing procedure would be detected. This spontaneous reversion rate was also compared with historical values for this laboratory and those cited in Maron and Ames (2) . Sterility and strain verification controls were run concurrently. All reagents, test compounds, and media were checked for sterility by plating samples of each on MG. media and incubating them at 37 0 C with the test plates. The Salmonella strains were verified by a standard battery of tests.
The intearity of the different Salmonella strains used in the assay was verified by the following standard tests:
-Lask of growth (inhibition) in the presence of crystal violet which indicates that the prerequisite alteration of the lipopolysaccharide layer (LP) of the cell wall is present.
-Growth in the presence of ampicillin-impregnated disks which indicates the presence of an ampicillin-resistant R Factor in all strains except TA1537 and TA1538.
-Lack of growth (inhibition) following exposure to ultraviolet light which indicates the absence of the DNA excision-repair mechanism (for all strains except TAl02).
Six known mutagens were tested as positive controls to confirm the responsiveness of the strains to the mutation process. Each strain must be tested with at least one Positive control but may be tested with several. 
Data Interpretation
According to Brusick (6) , a compound is considered mutagenic if a positive dose response (correlated dose response) over three dose concentrations is achieved with at least the highest dose yielding a revertant colony count greater than or equal to twice the spontaneous colony count for the tester strains TA98 and TA100, or three times the spontaneous colony count for strains TA1537 and TA1538 (2, 4) . A strong correlated dose response in strain TAI00 without a doubling of the individual colony count may also be considered positive.
Maron and Ames (2) consider a compound mutagenic in tester strains TA97 and TA102 if a correlated dose response over three concentrations is achieved with the highest dose yielding a revertant colony count greater than or equal to twice the spontaneous colony count.
Deviations from the Protocol/SOP Results with TA1535 were not obtained due to technical error. Since the test compound was negative in the other strains, conducting a special assay for TA1535 was deemed unnecessary.
Storage of the Raw Data and Final Report
A copy of the final report, study protocols, raw data, SOPs, and an aliquot of the test compound will be retained in the LAIR Archives.
RESULTS
On 16 May 1986, the toxicity of 1,3-BIS[3-(l-OCTOXYMETHYL) IMIDAZOLIUM]PROPANE DICHLORIDE DIHYDRATE was determined ( Table 1) .
For this experiment all sterility, strain verification, and negative controls were normal ( Table  1) .
Exposure of the tester strain (TAI00) to the three highest doses showed a decrease in the number of macrocolonies, and an observable reduction in the density of the background lawn, indicating chemical toxicity. Therefore, the highest dose selected for the mutagenicity test was 0.04 mg/plate. Normal results were obtained for all sterility and strain verification tests during the Ames Test performed on 20-22 August 1986 ( Table 2) .
Some of the TAl00 plates showed excessive clumping of the bacteria, presumably due to inadequate vortexing before plating. An accurate colony count on these plates could not be obtained. The data provided by the remaining strains are sufficient to reach a conclusion on the mutagenic potential of the test compound. 1,3-BIS[3-(I-OCTOXYMETHYL) IMIDAZOLIUM]PROPANE DICHLORIDE DIHYDRATE did not induce any appreciable increase in the revertant colony counts relative to those of the negative control cultures ( Table 3) .
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